Explore
Amyloid-beta clearance in Alzheimer's disease
Robert Marr and Eliezer Masliah
2015
0 Ungluers have
Faved this Work
Login to Fave
Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogenesis and the development of effective treatments. This topic focuses on the issues related to Aß clearance in AD. The topics covered include proteases that degrade Aß and their localization, regulation, and functions. This topic also covers issues related to clearance through uptake by glia and through low-density lipoprotein (LDL) receptor mediated mechanisms. Signal transduction related to AD pathology and clearance is also addressed. Finally, immunotherapy and other novel therapeutic approaches are discussed.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 146 times via unglue.it ebook links.
- 11 - epub (CC BY) at Unglue.it.
- 10 - epub (CC BY) at Unglue.it.
- 44 - mobi (CC BY) at Unglue.it.
- 43 - epub (CC BY) at Unglue.it.
- 32 - pdf (CC BY) at Unglue.it.
Keywords
- Alzheimer's disease
- amyloid-beta
- Clearance
- LDL receptors
- Proteases
- signal transduction
- thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences
Links
DOI: 10.3389/978-2-88919-443-8Editions